Pharsight

Amitiza patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5284858 SUCAMPO PHARMA LLC Prostaglandins E and anti ulcers containing same
Jul, 2014

(9 years ago)

US6414016 SUCAMPO PHARMA LLC Anti-constipation composition
Sep, 2020

(3 years ago)

US8114890 SUCAMPO PHARMA LLC Anti-constipation composition
Sep, 2020

(3 years ago)

US8071613 SUCAMPO PHARMA LLC Anti-constipation composition
Sep, 2020

(3 years ago)

US7417067 SUCAMPO PHARMA LLC Composition and method for stabilizing the same
Oct, 2020

(3 years ago)

US8097649 SUCAMPO PHARMA LLC Composition and method for stabilizing the same
Oct, 2020

(3 years ago)

US6583174 SUCAMPO PHARMA LLC Composition and method for stabilizing the same
Oct, 2020

(3 years ago)

US8088934 SUCAMPO PHARMA LLC Composition and method for stabilizing the same
May, 2021

(3 years ago)

US7064148 SUCAMPO PHARMA LLC Chloride channel opener
Aug, 2022

(1 year, 8 months ago)

US8097653 SUCAMPO PHARMA LLC Dosage unit comprising a prostaglandin analog for treating constipation
Nov, 2022

(1 year, 6 months ago)

US8389542 SUCAMPO PHARMA LLC Dosage unit comprising a prostaglandin analog for treating constipation
Nov, 2022

(1 year, 6 months ago)

US6982283 SUCAMPO PHARMA LLC Method for treating drug-induced constipation
Dec, 2022

(1 year, 5 months ago)

US7795312 SUCAMPO PHARMA LLC Method for treating abdominal discomfort
Sep, 2024

(3 months from now)

US8748481 SUCAMPO PHARMA LLC Method for treating gastrointestinal disorder
Sep, 2025

(1 year, 3 months from now)

US8338639 SUCAMPO PHARMA LLC Soft-gelatin capsule formulation
Jan, 2027

(2 years from now)

US8779187 SUCAMPO PHARMA LLC Soft-gelatin capsule formulation
Jan, 2027

(2 years from now)

US8026393 SUCAMPO PHARMA LLC Soft-gelatin capsule formulation
Oct, 2027

(3 years from now)

Amitiza is owned by Sucampo Pharma Llc.

Amitiza contains Lubiprostone.

Amitiza has a total of 17 drug patents out of which 12 drug patents have expired.

Expired drug patents of Amitiza are:

  • US5284858
  • US6414016
  • US8114890
  • US8071613
  • US7417067
  • US8097649
  • US6583174
  • US8088934
  • US7064148
  • US8097653
  • US8389542
  • US6982283

Amitiza was authorised for market use on 29 April, 2008.

Amitiza is available in capsule;oral dosage forms.

Amitiza can be used as method of relieving or preventing constipation in a human constipated patient, method for relieving constipation in a human patient that comprises administering to the patient a dosage unit comprising (i) 24mcg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient, method for treating irritable bowel syndrome and method for treating abdominal discomfort associated with irritable bowel syndrome, method for the long term treatment of chronic constipation in a human subject, method for relieving or treating constipation in a patient with irritable bowel syndrome, use in relieving or preventing constipation in a human patient with a dosage unit comprising 24microg+/- 10% of a drug substance and a pharmaceutically suitable excipient, method for treating constipation by opening cic channels in a mammalian subject, method for treating opioid-induced constipation.

The generics of Amitiza are possible to be released after 25 October, 2027.

Drug Exclusivity Drug Exclusivity Expiration
M(M-225) Apr 26, 2021
New Indication(I-670) Apr 19, 2016

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using LUBIPROSTONE ingredient

Market Authorisation Date: 29 April, 2008

Treatment: Method of relieving or preventing constipation in a human constipated patient; Method for relieving or treating constipation in a patient with irritable bowel syndrome; Method for treating constipati...

Dosage: CAPSULE;ORAL

How can I launch a generic of AMITIZA before it's drug patent expiration?
More Information on Dosage

AMITIZA family patents

Family Patents